Autor(es)
Afiliação
Resumo em Inglês
The COVID-19 pandemic is one of the greatest health and societal
challenges that the world has collectively faced in many decades.
Policy, public health, clinical and individual decision makers are
actively seeking evidence and evidence-based guidance (e.g. health
technology assessments, clinical practice guidelines) on prevention,
management and mitigation of the health, social and economic
impacts of COVID-19. As a result, there has been a dramatic global
increase in basic and applied health (and to a lesser extent social
and economic) research. Given that individual studies are rarely
sufficient to guide policy, clinical and individual decisions, and
the evidence base is rapidly evolving, decision makers need highquality,
context-relevant evidence syntheses and trustworthy
guidance more than ever. It was heartening then, to see a dramatic
increase in evidence synthesis, guidance and associated decision
support activities globally to meet the needs of the pandemic
during the first half of 2020.Many of the eventual partners in COVID-END were involved in
some type of evidence synthesis, guidance and support activities
when COVID-19 struck. These partners rapidly pivoted to focus
their work on COVID-19. We (JMG, JNL) observed that during the
initial stages of the pandemic, the evidence synthesis response
largely focused on rapid reviews, which were rapidly out of date
despite the ongoing relevance of the review question and were of
variable quality, and that guidance development largely focused
on expert opinion. There was also huge duplication of effort
globally, creating a major noise to signal problem. We decided
to convene a series of exploratory meetings in early April of the
key global evidence synthesis, guidance and decision support
organizations to see whether other groups shared our concerns.We also explored whether there was an appetite to work together
to promote collaboration, improve the efficiency of evidence
synthesis and guidance production and decision support activities,
and reduce inappropriate duplication of effort in order to maximize
the impact of the global evidence response to COVID-19. Following
these meetings, we established COVID-END: the COVID-19 Evidence
Network to support Decision-making (covid-end.org/), as a
time-limited network of global evidence synthesis, guidance and
decision support organizations that aims better to co-ordinate their
collective evidence response to the pandemic.
Editor
John Wiley & Sons
Referência
GRIMSHAW, Jeremy M. et al. COVID-END: an international network to better co-ordinate and maximize the impact of the global evidence synthesis and guidance response to COVID-19. Cochrane Database of Systematic Reviews, [s.l], v.12, p.4-8, 2020. Supl. 1.
DOI
10.1002/14651858.CD202002
ISSN
1465-1858
Notas
COVID-END: Barreto, J. M. (Jorge Otávio Maia Barreto) – Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.; Al-Khateeb, S. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Akl, E. A. – American University of Beirut. Clinical Research Institute. Beirut, Lebanon.; Bai, Z. – Nanjing University of Science and Technology. Evidence-based Social Science and Health Research Center. Nanjing, JS, China.; Brandt, L. – MAGIC Evidence Ecosystem Foundation. Norway.; Brassey, J. – Trip Database. United Kingdom.; Boutron, I. – Université de Paris. Centre of Research in Epidemiology and Statistics. Paris, France.; Bullock, H.L. – McMaster University. McMaster Health Forum. RISE. Hamilton, ON, Canada.; Burke, N.N. – Cochrane Ireland. Galway, Ireland / Evidence Synthesis Ireland. Galway, Ireland; Chen, Y. –Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS , China. ; Ciurea, I. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Dieyi, N.U. – Memorial University of Newfoundland and Labrador. St. John's, N.L, Canada.; de Haan, S. – Cochrane. Heidelberglaan, Utrecht, Netherlands.; Dion, A. – Ottawa Hospital Research Institute. RISE. Ottawa, ON, Canada.; Dobbins, M. – McMaster University. National Collaborating Centre for Methods and Tools. Hamilton, ON, Canada.; El-Jardali, F. – American University of Beirut. Knowledge to Policy (K2P) Center. Beirut, Lebanon.; Elliott, J.H. – Cochrane Australia. Melbourne, VIC, Australia. ; Florez, I.D. – University of Antioquia. Medellín, ANT, Colombia.; Gough, D. – University College London. EPPI-Centre. London, United Kingdom.; Greenhalgh, T. – University of Oxford. Interdisciplinary Research In Health Sciences Research Group. Oxford, United Kingdom.; Henry, L. – Lucy Henry Consulting. Ottawa, ON, Canada.; Iorio, A. – McMaster University. Department of Health Research Methods, Evidence and Impact. Hamilton, ON, Canada.; Kamga, E.B. – Effective Basic Services (eBASE) Africa. Bamenda, Cameroon.; Kawala, B.A. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Kawooya, I. – Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Kayongo, E. – Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Kredo, T. – South African Medical Research Council, Cape Town, South Afric. Langer, L – University of Johannesburg. Africa Centre for Evidence. Johannesburg, South Africa.; Lewin, S. – Norwegian Institute of Public Health. Cochrane EPOC. Oslo, Norway / South African Medical Research Council, Cape Town, South Africa.; Lewis, S.Z. – EBQ Consulting, LLC. Austin, TX, United States.; Lockwood, C. – University of Adelaide. Faculty of Health and Medical Sciences. Joanna Briggs Institute. Adelaide, SA, Australia.; Lotfi,T. – American University of Beirut. Global Evidence Synthesis Initiative. Beirut, Lebanon / McMaster University. Health Research Methods, Evidence & Impact. Ottawa, ON, Canada.; Mavergames, C. – Germany Cochrane. Freiburg im Breisgau, Germany.; McCaul, M. – Stellenbosch University. Department of Global Health. Centre for Evidence Based Health Care. Stellenbosch, South Africa.; McQuillan, R. University of Edinburgh. Usher Institute. Edinburgh, United Kingdom.; Mijumbi-Deve, R. Makerere University. College of Health Sciences. The Centre for Rapid Evidence Synthesis. Kampala, Uganda.; Moat, K.A. – McMaster University. McMaster Health Forum. Hamilton, ON, Canada.; Munn, Z. – Guidelines International Network. Scotland / University of Adelaide. Faculty of Health and Medical Sciences. Joanna Briggs Institute. Adelaide, SA, Australia.; Nakibuuka, L.S. – Memorial University of Newfoundland and Labrador. St. John's, N.L, Canada.; Ndagire, R. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Nunan, D. – University of Oxford. Oxford Centre for Evidence-Based Medicine. Oxford. United Kingdom.; Obuku, E.A. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Ocan, M. – Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Okwen, P. M. – Effective Basic Services (eBASE) Africa. Bamenda, Cameroon.; Oliver, S. R. – University College London. EPPI-Centre. London, United Kingdom.; Ooi, C.P. – Universiti Putra Malaysia. Serdang, Malaysia.; Osheroff, J. A. – Initiative COVID-19 Guidance to Action Collaborative. AHRQ evidence-based Care Transformation Support. TMIT Consulting and Chair. Rockville, MD, United States.; Rada, G. – Epistemonikos Foundation, Santiago, Chile.; Reveiz, L. - Pan American Health Organization. Washington, D.C., United States.; Roy, D. – Institut National d’Excellence en Santé et en Services Sociaux. Quebec, ON, Canada.; Smith, M. – Cochrane consumer, Canada.; Snilstveit, B. – International Initiative for Impact Evaluation. London, United Kingdom.; Stewart, L.A. – University of York. Centre for Reviews and Dissemination. York, United Kingdom.; Stewart, R. – University of Johannesburg. Africa Centre for Evidence. Johannesburg, South Africa.; Sutherland, K. – Agency for Clinical Innovation. St Leonards, NSW, Australia.; Taske, N. L. – National Institute for Health and Care Excellence. London, United Kingdom.; Taylor, B.H. – Evidence Aid. Oxford, United Kingdom.; Thomas, J. – University College London. EPPI-Centre. London, United Kingdom.; Tricco, A.C. – Unity Health Toronto. Li Ka Shing Knowledge Institute of St. Michael’s Hospital. Toronto, ON, Canada.; Vandvik, P.O. – MAGIC Evidence Ecosystem Foundation. Norway.; Vist, G.E. – Norwegian Institute of Public Health. Oslo, Norway. ; Wangi, N.R. Makerere University. Africa Centre for Systematic Reviews and Knowledge Translation. Kampala, Uganda.; Welch, V. A. – Campbell Collaboration. Canada.; Wild, C. – European Network for Health Technology Assessment. Vienna, Austria.; Young, T. – Stellenbosch University. Department of Global Health. Centre for Evidence Based Health Care. Stellenbosch, South Africa.; Yu, X. – Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS, China.; Zhu, Y. – Lanzhou University. Evidence Based Medicine Centre. Lanzhou, GS, China.
Compartilhar